Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

Ongoing clinical trials for the management of the COVID-19 pandemic

MP Lythgoe, P Middleton - Trends in pharmacological sciences, 2020 - cell.com
COVID-19 has rapidly developed into a worldwide pandemic with a significant health and
economic burden. There are currently no approved treatments or preventative therapeutic …

Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …

Current pharmacological treatments for SARS-COV-2: A narrative review

G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …

[PDF][PDF] COVID-19 drug therapy

T Smith, J Bushek, A LeClaire, T Prosser - Elsevier, 2020 - repository.phb.ac.id
• There are no specific therapies approved by the US Food and Drug Administration (FDA)
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes …

Pharmacotherapy in COVID-19; A narrative review for emergency providers

N Mehta, M Mazer-Amirshahi, N Alkindi… - The American journal of …, 2020 - Elsevier
Introduction The COVID-19 pandemic has been particularly challenging due to a lack of
established therapies and treatment guidelines. With the rapid transmission of disease, even …